BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27896513)

  • 1. Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients.
    Liao CT; Wen YW; Lee SR; Liu TW; Tsai ST; Tsai MH; Lin JC; Lou PJ; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chien CY; Chen WC; Lee LY; Lin CY; Wang HM; Ng SH; Lin CH; Fang TJ; Huang SF; Kang CJ; Chang KP; Yang LY; Yen TC;
    Ann Surg Oncol; 2017 Mar; 24(3):785-793. PubMed ID: 27896513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
    Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.
    Takahashi H; Yanamoto S; Yamada S; Umeda M; Shigeta T; Minamikawa T; Shibuya Y; Komori T; Shiraishi T; Asahina I; Yokoo S; Ri S
    Int J Oral Maxillofac Surg; 2014 Jun; 43(6):680-5. PubMed ID: 24387949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Fang KH; Wang YC; Chang YL; Huang YC; Tsai CY; Yen TC
    Oral Oncol; 2013 Mar; 49(3):230-6. PubMed ID: 23063612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy.
    Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Tsao CK; Huang YC; Yen TC
    Oral Oncol; 2012 Apr; 48(4):329-36. PubMed ID: 22104249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Cancer; 2008 Jan; 112(1):94-103. PubMed ID: 18022917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.
    Elbers JBW; Al-Mamgani A; Paping D; van den Brekel MWM; Jóźwiak K; de Boer JP; Karakullukcu B; Verheij M; Zuur CL
    Oral Oncol; 2017 Dec; 75():163-168. PubMed ID: 29224815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma.
    Liao CT; Chen HN; Wen YW; Lee SR; Ng SH; Liu TW; Tsai ST; Tsai MH; Lin JC; Lou PJ; Wang CP; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chien CY; Chen WC; Lee LY; Lin CY; Wang HM; Lin CH; Fang TJ; Huang SF; Kang CJ; Chang KP; Yang LY; Yen TC
    Eur J Cancer; 2017 Feb; 72():226-234. PubMed ID: 28056426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters and outcomes in 525 patients operated on for oral squamous cell carcinoma.
    Garzino-Demo P; Zavattero E; Franco P; Fasolis M; Tanteri G; Mettus A; Tosco P; Chiusa L; Airoldi M; Ostellino O; Schena M; Rampino M; Ricardi U; Evangelista A; Merletti F; Berrone S; Ramieri G
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1414-21. PubMed ID: 27485718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.
    Liao CT; Lin CY; Fan KH; Wang HM; Ng SH; Lee LY; Hsueh C; Chen IH; Huang SF; Kang CJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):284-90. PubMed ID: 21075550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.
    Mizrachi A; Migliacci JC; Montero PH; McBride S; Shah JP; Patel SG; Ganly I
    Oral Oncol; 2018 Mar; 78():94-101. PubMed ID: 29496065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineural invasion in T1 oral squamous cell carcinoma indicates the need for aggressive elective neck dissection.
    Tai SK; Li WY; Yang MH; Chu PY; Wang YF
    Am J Surg Pathol; 2013 Aug; 37(8):1164-72. PubMed ID: 23681077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.
    Tangthongkum M; Kirtsreesakul V; Supanimitjaroenporn P; Leelasawatsuk P
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2567-2572. PubMed ID: 28321535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraomohyoid neck dissection and modified radical neck dissection for clinically node-negative oral squamous cell carcinoma: a prospective study of prognosis, complications and quality of life.
    Guo CB; Feng Z; Zhang JG; Peng X; Cai ZG; Mao C; Zhang Y; Yu GY; Li JN; Niu LX
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1885-90. PubMed ID: 25175079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Nodal Level Distribution on Survival in Oral Cavity Squamous Cell Carcinoma: A Population-Based Study.
    Marchiano E; Patel TD; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 Jul; 155(1):99-105. PubMed ID: 26980921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research.
    Amit M; Yen TC; Liao CT; Binenbaum Y; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Cernea CR; Brandao SJ; Kreppel M; Zöller J; Fliss D; Bachar G; Shpitzer T; Bolzoni VA; Patel PR; Jonnalagadda S; Robbins KT; Shah JP; Patel SG; Gil Z;
    Ann Surg Oncol; 2013 Oct; 20(11):3575-81. PubMed ID: 23775408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
    Wedemeyer I; Kreppel M; Scheer M; Zöller JE; Büttner R; Drebber U
    Oral Dis; 2014 Apr; 20(3):e81-9. PubMed ID: 23746299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.